PPAR-alpha is a therapeutic target for chronic lymphocytic leukemia
DE Spaner, E Lee, Y Shi, F Wen, Y Li, S Tung… - Leukemia, 2013 - nature.com
Chronic lymphocytic leukemia (CLL) cells with aggressive clinical properties express
lipoprotein lipase (LPL), which generates activating ligands for the nuclear receptor …
lipoprotein lipase (LPL), which generates activating ligands for the nuclear receptor …